መነሻ › አኩት ማይሎይድ ሊውኬሚያ › North Carolina › Winston-Salem
በWinston-Salem፣ NC ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ 18 ጥናቶች በWinston-Salem እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Novant Health Forsyth Medical Center, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Wake Forest University Health Sciences, Winston-Salem
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Novant Health Forsyth Medical Center, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Novant Health Winston Salem, Winston-Salem
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Wake Forest University Health Sciences, Winston-Salem
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Wake Forest University Health Sciences, Winston-Salem
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Wake Forest University Health Sciences, Winston-Salem
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Wake Forest University Health Sciences, Winston-Salem
Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Wake Forest University Health Sciences, Winston-Salem
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Wake Forest University Health Sciences, Winston-Salem
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይ
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
ተሳታዮችን በመፈለግ ላይ
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology, Winston-Salem
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Wake Forest Baptist Health, Winston-Salem
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Atrium Wake Forest Baptist Medical Center, Winston-Salem
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Novant Health Cancer Institute, Winston-Salem
በሌሎች ከተሞች ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ጥናቶች
- Houston, TX85 ጥናቶች
- New York City, NY51 ጥናቶች
- Boston, MA44 ጥናቶች
- Seattle, WA41 ጥናቶች
- Baldwin Park, CA40 ጥናቶች
- Columbus, OH35 ጥናቶች
- Philadelphia, PA34 ጥናቶች
- Durham, NC33 ጥናቶች
- Atlanta, GA31 ጥናቶች
- Tampa, FL29 ጥናቶች
- Chicago, IL26 ጥናቶች
- Portland, OR25 ጥናቶች
በWinston-Salem ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)19 ጥናቶች
- Multiple Myeloma14 ጥናቶች
- የጡንቻ ካንሰር14 ጥናቶች
- የልብና የደም ዝውውር ሕመም14 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር12 ጥናቶች
- ሲ.ኦ.ፒ.ዲ10 ጥናቶች
- የእንቁላል ካንሰር10 ጥናቶች
- የ2 ዓይነት ስኳረት9 ጥናቶች
- ማይሎዲስፕላስቲክ ሲንድሮሞች9 ጥናቶች
- ግሊዎብላስቶማ8 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ8 ጥናቶች
- የሳንባ ካንሰር8 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።